To determine whether the observed suppression of FAS protein by 6-TG and 6‐MP in A253 cells was cell type-specific, we also tested their effects in the Reh and SupB15 leukemia cell lines, the DU-145 prostate cancer cell line, and the HeLa human cervical cancer cell line. This evidence concerns the gene FAS and prostate carcinoma.